Medipa S R O

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Depression5 trials
• Insomnia1 trial
• Schizophrenia1 trial

Phase

• Phase 34 trials
• Phase 22 trials

Status

• Recruiting3 trials
• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• Seaport Therapeutics2 trials
• Janssen Cilag International1 trial
• Janssen Research & Development, LLC1 trial
• Newron Pharmaceuticals S.p.A.1 trial
• Vanda Pharmaceuticals1 trial

Running trials

• Active, not recruiting

  Evenamide in patients with treatment-resistant schizophrenia not responding to antipsychotics

  2024-519836-18-00· Phase 3· Newron Pharmaceuticals S.p.A.· Source

• Enrolling by invitation

  An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)

  NCT07161700· Phase 2· Seaport Therapeutics· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

  NCT07065240· Phase 2· Seaport Therapeutics· Source

• Recruiting

  Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

  NCT06830044· Phase 3· Vanda Pharmaceuticals· Source

• Recruiting

  Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

  NCT06559306· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Depression3 recruiting

Closed trials

• Completed

  A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjunctive Aticaprant Plus an Antidepressant for Relapse Prevention in Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia

  2024-511057-22-00· Phase 3· Janssen Cilag International· Source